OBJECTIVE: To investigate the association of serum lipids and other risk factors with diabetic retinopathy (DR) in Chinese type 2 diabetic patients. METHODS: Five hundred and twenty-three type 2 diabetic patients underwent ophthalmic examination by experienced retinal specialists to assess their DR. Serum lipids, including triglycerides, total cholesterol, high density lipoprotein cholesterol (HDLC), and low density lipoprotein cholesterol (LDLC), were measured using Roche automated clinical chemistry analyzers. The concentration of very low density lipoprotein cholesterol (VLDLC) was calculated based on total cholesterol, HDLC and LDLC. Hyperlipidemia was defined as a total cholesterol concentration of 6.2 mmol/L or higher or the use of lipid-lowering medications. The association of risk factors with any DR or proliferative diabetic retinopathy (PDR) was assessed using the odds ratio (OR) and its 95% confidence interval (CI), calculated from logistic regression models. RESULTS: In multivariate logistic regression models, hyperlipidemia (OR=2.39, 95% CI: 1.02-5.66), higher VLDLC (OR=1.59, 95% CI: 1.14-2.23), and higher triglyceride (OR=1.18, 95% CI: 1.03-1.37) were associated with increased risk of DR. A longer diabetic duration was associated with increased risk of DR (P<0.0001) and PDR (P=0.002) in a dose-response manner. Higher systolic blood pressure (P=0.02) and higher serum creatinine (P=0.01) were independently associated with increased risk of DR, and female gender was associated with increased risk of PDR (P=0.03). CONCLUSIONS: Among Chinese type 2 diabetic patients, hyperlipidemia, higher VLDLC, and higher triglyceride were independently associated with increased risk of DR, suggesting control of serum lipids may decrease the risk of DR.
OBJECTIVE: To investigate the association of serum lipids and other risk factors with diabetic retinopathy (DR) in Chinese type 2 diabeticpatients. METHODS: Five hundred and twenty-three type 2 diabeticpatients underwent ophthalmic examination by experienced retinal specialists to assess their DR. Serum lipids, including triglycerides, total cholesterol, high density lipoprotein cholesterol (HDLC), and low density lipoprotein cholesterol (LDLC), were measured using Roche automated clinical chemistry analyzers. The concentration of very low density lipoprotein cholesterol (VLDLC) was calculated based on total cholesterol, HDLC and LDLC. Hyperlipidemia was defined as a total cholesterol concentration of 6.2 mmol/L or higher or the use of lipid-lowering medications. The association of risk factors with any DR or proliferative diabetic retinopathy (PDR) was assessed using the odds ratio (OR) and its 95% confidence interval (CI), calculated from logistic regression models. RESULTS: In multivariate logistic regression models, hyperlipidemia (OR=2.39, 95% CI: 1.02-5.66), higher VLDLC (OR=1.59, 95% CI: 1.14-2.23), and higher triglyceride (OR=1.18, 95% CI: 1.03-1.37) were associated with increased risk of DR. A longer diabetic duration was associated with increased risk of DR (P<0.0001) and PDR (P=0.002) in a dose-response manner. Higher systolic blood pressure (P=0.02) and higher serum creatinine (P=0.01) were independently associated with increased risk of DR, and female gender was associated with increased risk of PDR (P=0.03). CONCLUSIONS: Among Chinese type 2 diabeticpatients, hyperlipidemia, higher VLDLC, and higher triglyceride were independently associated with increased risk of DR, suggesting control of serum lipids may decrease the risk of DR.
Authors: Jie Xu; Wen Bin Wei; Ming Xia Yuan; Shen Yuan Yuan; Gang Wan; Yuan Yuan Zheng; Yi Bin Li; Shuang Wang; Liang Xu; Han Jing Fu; Liang Xiang Zhu; Xiang Lei Pu; Jian Dong Zhang; Xue Ping Du; Yu Lin Li; Yu Ji; Xiao Ning Gu; Yue Li; Su Fang Pan; Xue Li Cui; Wei Bai; Yu Jie Chen; Zi Min Wang; Qing Sheng Zhu; Ying Gao; De Yuan Liu; Yun Tao Ji; Ze Yang; Jost B Jonas Journal: Retina Date: 2012-02 Impact factor: 4.256
Authors: Feng Hua Wang; Yuan Bo Liang; Xiao Yan Peng; Jie Jin Wang; Feng Zhang; Wen Bin Wei; Lan Ping Sun; David S Friedman; Ning Li Wang; Tien Yin Wong Journal: Acta Ophthalmol Date: 2011-03-04 Impact factor: 3.761
Authors: D P Liu; L Molyneaux; E Chua; Y Z Wang; C R Wu; H Jing; L N Hu; Y J Liu; Z R Xu; D K Yue Journal: Diabetes Res Clin Pract Date: 2002-05 Impact factor: 5.602
Authors: S M Haffner; B D Mitchell; S E Moss; M P Stern; H P Hazuda; J Patterson; W A Van Heuven; R Klein Journal: Ann Epidemiol Date: 1993-01 Impact factor: 3.797
Authors: Neil T Raymond; Lakshminarayanan Varadhan; Dilini R Reynold; Kate Bush; Sailesh Sankaranarayanan; Srikanth Bellary; Anthony H Barnett; Sudhesh Kumar; J Paul O'Hare Journal: Diabetes Care Date: 2008-12-15 Impact factor: 19.112
Authors: Rayne R Lim; DeAna G Grant; T Dylan Olver; Jaume Padilla; Alana M Czajkowski; Teagan R Schnurbusch; Rajiv R Mohan; Dean P Hainsworth; Eric M Walters; Shyam S Chaurasia Journal: Invest Ophthalmol Vis Sci Date: 2018-05-01 Impact factor: 4.799
Authors: Bassirou A M Mounirou; Nouhou D Adam; Abba K H Yakoura; Mahamane S M Aminou; Yu T Liu; Li Y Tan Journal: Indian J Endocrinol Metab Date: 2022-06-06